Publications by authors named "Christopher Pleyer"

Claim this Profile
P
Prolonged Heparin Re-Exposure in a Patient With Previous Heparin-Induced Thrombocytopenia (HIT).
Christopher Pleyer, Gina Ney, Khanh Nghiem, Shelley Kalsi, Charles Bolan

Int J Lab Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interruption of BTK inhibitor improves response to SARS-CoV-2 booster vaccination in patients with CLL.
Emily Tomasulo, Shira Paul, Rui Mu, Xin Tian, Jonathan Chen, Christopher Pleyer

Leuk Lymphoma· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL.
Christopher Pleyer, Kerry J Laing, Mir A Ali, Christopher L McClurkan, Susan Soto

Blood Adv· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study.
Sanjal Desai, Clifton Mo, Erika M Gaglione, Constance M Yuan, Maryalice Stetler-Stevenson, Christopher Pleyer

Leuk Lymphoma· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 vaccines for patients with haematological conditions.
Clare Sun, Christopher Pleyer, Adrian Wiestner

Lancet Haematol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines.
Christopher Pleyer, Mir A Ali, Jeffrey I Cohen, Xin Tian, Susan Soto

Blood· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of ibrutinib and short-course fludarabine in previously untreated patients with chronic lymphocytic leukemia.
Christopher Pleyer, Xin Tian, Shakuntala Rampertaap, Rui Mu, Susan Soto

Am J Hematol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors.
Christopher Pleyer, Clare Sun, Sanjal Desai, Inhye E Ahn, Xin Tian

Leuk Lymphoma· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib.
Clare Sun, Pia Nierman, Ellen K Kendall, Jean Cheung, Michael Gulrajani, Christopher Pleyer

Blood· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological changes with kinase inhibitor therapy for chronic lymphocytic leukemia.
Christopher Pleyer, Adrian Wiestner, Clare Sun

Leuk Lymphoma· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phrenic nerve paralysis induced by brachial plexus block.
Aaron C Hamilton, Christopher Pleyer

Cleve Clin J Med· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysozyme amyloidosis - a case report and review of the literature.
Christopher Pleyer, Jan Flesche, Fahad Saeed

Clin Nephrol Case Stud· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis